Christian Klein

Person

Weilheim, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies binding to HLA-A2/WT1
- Patent number 12,098,213
- Issue date Sep 24, 2024
- HOFFMANN-LA ROCHE INC.
- Joerg Benz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination therapy of a type II anti-CD20 antibody with a selectiv...
- Patent number 11,590,128
- Issue date Feb 28, 2023
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy of a type II anti-CD20 antibody with a selectiv...
- Patent number 11,413,282
- Issue date Aug 16, 2022
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy of a type II anti-CD20 antibody with a selectiv...
- Patent number 11,110,087
- Issue date Sep 7, 2021
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy of a type II anti-CD20 antibody with a selectiv...
- Patent number 10,993,942
- Issue date May 4, 2021
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bivalent, bispecific antibodies
- Patent number 10,927,163
- Issue date Feb 23, 2021
- Hoffmann-La Roche, Inc.
- Christian Klein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bivalent, bispecific antibodies
- Patent number 10,138,293
- Issue date Nov 27, 2018
- Hoffmann-La Roche, Inc.
- Christian Klein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fc-free antibodies comprising two fab-fragments and methods of use
- Patent number 10,087,250
- Issue date Oct 2, 2018
- Roche Glycart AG
- Peter Bruenker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Promoter
- Patent number 9,926,567
- Issue date Mar 27, 2018
- Hoffmann-La Roche, Inc.
- Christian Klein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Bispecific anti-VEGF/anti-ANG-2 antibodies
- Patent number 9,708,396
- Issue date Jul 18, 2017
- Hoffmann-La Roche Inc.
- Monika Baehner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy of a type II anti-CD20 antibody with a selectiv...
- Patent number 9,539,251
- Issue date Jan 10, 2017
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against human angiopoietin 2
- Patent number 9,340,609
- Issue date May 17, 2016
- HOFFMANN-LA ROCHE INC.
- Ulrich Brinkmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bivalent, bispecific antibodies
- Patent number 9,266,967
- Issue date Feb 23, 2016
- Hoffmann-La Roche, Inc.
- Christian Klein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies against human angiopoietin 2
- Patent number 9,109,027
- Issue date Aug 18, 2015
- Hoffman-La Roche Inc.
- Ulrich Brinkmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Promoter
- Patent number 9,080,183
- Issue date Jul 14, 2015
- Hoffmann-La Roche Inc.
- Christian Klein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific anti-VEGF/anti-ANG-2 antibodies
- Patent number 8,703,130
- Issue date Apr 22, 2014
- Hoffmann-La Roche, Inc.
- Monika Baehner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against human angiopoietin 2
- Patent number 8,399,626
- Issue date Mar 19, 2013
- Hoffmann-La Roche Inc.
- Ulrich Brinkmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against human angiopoietin 2
- Patent number 8,361,747
- Issue date Jan 29, 2013
- Hoffmann-La Roche Inc.
- Ulrich Brinkmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific anti-VEGF/anti-ANG-2 antibodies
- Patent number 8,268,314
- Issue date Sep 18, 2012
- Hoffmann-La Roche Inc.
- Monika Baehner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bivalent, bispecific antibodies
- Patent number 8,242,247
- Issue date Aug 14, 2012
- Hoffmann-La Roche Inc.
- Christian Klein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bivalent, bispecific antibodies
- Patent number 8,227,577
- Issue date Jul 24, 2012
- Hoffman-La Roche Inc.
- Christian Klein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies against human angiopoietin 2
- Patent number 8,133,979
- Issue date Mar 13, 2012
- Hoffmann-La Roche Inc.
- Ulrich Brinkmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for the recombinant production and purification of protein k...
- Patent number 7,393,936
- Issue date Jul 1, 2008
- Hoff Hoffmann-La Roche Inc.
- Hubert Hertenberger
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method and device for obtaining and detecting immunologically activ...
- Patent number 6,605,444
- Issue date Aug 12, 2003
- Securetec Detektions-Systems AG
- Christian Klein
- G01 - MEASURING TESTING
Information Patent Grant
Method of detecting surface contamination by an analyte
- Patent number 6,514,773
- Issue date Feb 4, 2003
- Securetec Detektions-Systeme AG
- Christian Klein
- G01 - MEASURING TESTING
Information Patent Grant
Analytical test element with a blister filled with liquid
- Patent number 6,159,747
- Issue date Dec 12, 2000
- Roche Diagnostics GmbH
- Herbert Harttig
- G01 - MEASURING TESTING
Information Patent Grant
Peptides with a characteristic antigenic determinant of .alpha.1-mi...
- Patent number 6,153,192
- Issue date Nov 28, 2000
- Boehringer Mannheim GmbH
- Erhard Kopetzki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the production of substituted thiazoline-dioxetan subst...
- Patent number 5,994,552
- Issue date Nov 30, 1999
- Roche Diagnostics GmbH
- Rupert Herrmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activated amphetamines
- Patent number 5,976,812
- Issue date Nov 2, 1999
- Roche Diagnostics GmbH
- Erasmus Huber
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Universal binding film
- Patent number 5,763,191
- Issue date Jun 9, 1998
- Boehringer Mannheim GmbH
- Wolfgang Knoll
- B82 - NANO-TECHNOLOGY

Patents Applicationslast 30 patents

Information Patent Application
COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCONJUGATE A...
- Publication number 20240262913
- Publication date Aug 8, 2024
- HOFFMANN-LA ROCHE INC.
- Laura CODARRI DEAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20240180901
- Publication date Jun 6, 2024
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20240108616
- Publication date Apr 4, 2024
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCONJUGATES...
- Publication number 20240092856
- Publication date Mar 21, 2024
- HOFFMANN-LA ROCHE INC.
- Marina BACAC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20240000776
- Publication date Jan 4, 2024
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES BINDING TO CD3 AND FOLR1
- Publication number 20230416411
- Publication date Dec 28, 2023
- HOFFMANN-LA ROCHE INC.
- Peter BRUENKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES
- Publication number 20230399391
- Publication date Dec 14, 2023
- HOFFMANN-LA ROCHE INC.
- Monika Baehner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEASE-ACTIVATED T CELL BISPECIFIC ANTIBODIES
- Publication number 20230287145
- Publication date Sep 14, 2023
- HOFFMANN-LA ROCHE INC.
- Peter BRUENKER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES WHICH BIND TO CANCER CELLS AND TARGET RADIONUCLIDES TO S...
- Publication number 20230272116
- Publication date Aug 31, 2023
- HOFFMANN-LA ROCHE INC.
- Alexander HAAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20230255959
- Publication date Aug 17, 2023
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2
- Publication number 20230227543
- Publication date Jul 20, 2023
- HOFFMANN-LA ROCHE INC.
- Ulrich Brinkmann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20230226045
- Publication date Jul 20, 2023
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PD1 ANTIBODIES AND METHODS OF USE
- Publication number 20230183349
- Publication date Jun 15, 2023
- HOFFMANN-LA ROCHE INC.
- Joerg BENZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies binding To HLA-A2/WT1
- Publication number 20220411534
- Publication date Dec 29, 2022
- HOFFMANN-LA ROCHE INC.
- Joerg Benz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20220370441
- Publication date Nov 24, 2022
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A HLA-A2/WT1 X CD3 BISPECIFIC ANTIBODY AN...
- Publication number 20220275093
- Publication date Sep 1, 2022
- HOFFMANN-LA ROCHE INC.
- Christian AUGSBERGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20220265642
- Publication date Aug 25, 2022
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20220211696
- Publication date Jul 7, 2022
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREVENTION OR MITIGATION OF T-CELL ENGAGING AGENT-RELATED ADVERSE E...
- Publication number 20220168418
- Publication date Jun 2, 2022
- HOFFMANN-LA ROCHE INC.
- Hélène Cécile HAEGEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIGEN BINDING MOLECULES COMPRISING LIPOCALIN MUTEINS
- Publication number 20220025069
- Publication date Jan 27, 2022
- HOFFMANN-LA ROCHE INC.
- Christina CLAUS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20220008413
- Publication date Jan 13, 2022
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2
- Publication number 20210388071
- Publication date Dec 16, 2021
- HOFFMANN-LA ROCHE INC.
- Ulrich Brinkmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIBODIES
- Publication number 20210309730
- Publication date Oct 7, 2021
- HOFFMANN-LA ROCHE INC.
- WOLFGANG SCHAEFER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20210177838
- Publication date Jun 17, 2021
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES
- Publication number 20210047394
- Publication date Feb 18, 2021
- HOFFMANN-LA ROCHE INC.
- Monika Baehner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2
- Publication number 20200262904
- Publication date Aug 20, 2020
- HOFFMANN-LA ROCHE INC.
- Ulrich Brinkmann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...
- Publication number 20200253963
- Publication date Aug 13, 2020
- Genentech, Inc.
- Deepak Sampath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIVALENT, BISPECIFIC ANTIBODIES
- Publication number 20190153071
- Publication date May 23, 2019
- Hoffmann-La Roche, Inc.
- Christian KLEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2
- Publication number 20180282404
- Publication date Oct 4, 2018
- HOFFMANN-LA ROCHE INC.
- Ulrich Brinkmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES
- Publication number 20170369566
- Publication date Dec 28, 2017
- HOFFMANN-LA ROCHE INC.
- Monika Baehner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Christian Klein

Person

Patents Grantslast 30 patents

Antibodies binding to HLA-A2/WT1

Combination therapy of a type II anti-CD20 antibody with a selectiv...

Combination therapy of a type II anti-CD20 antibody with a selectiv...

Combination therapy of a type II anti-CD20 antibody with a selectiv...

Combination therapy of a type II anti-CD20 antibody with a selectiv...

Bivalent, bispecific antibodies

Bivalent, bispecific antibodies

Fc-free antibodies comprising two fab-fragments and methods of use

Promoter

Bispecific anti-VEGF/anti-ANG-2 antibodies

Combination therapy of a type II anti-CD20 antibody with a selectiv...

Antibodies against human angiopoietin 2

Bivalent, bispecific antibodies

Antibodies against human angiopoietin 2

Promoter

Bispecific anti-VEGF/anti-ANG-2 antibodies

Antibodies against human angiopoietin 2

Antibodies against human angiopoietin 2

Bispecific anti-VEGF/anti-ANG-2 antibodies

Bivalent, bispecific antibodies

Bivalent, bispecific antibodies

Antibodies against human angiopoietin 2

Method for the recombinant production and purification of protein k...

Method and device for obtaining and detecting immunologically activ...

Method of detecting surface contamination by an analyte

Analytical test element with a blister filled with liquid

Peptides with a characteristic antigenic determinant of .alpha.1-mi...

Process for the production of substituted thiazoline-dioxetan subst...

Activated amphetamines

Universal binding film

Patents Applicationslast 30 patents

COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCONJUGATE A...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCONJUGATES...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

ANTIBODIES BINDING TO CD3 AND FOLR1

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

PROTEASE-ACTIVATED T CELL BISPECIFIC ANTIBODIES

ANTIBODIES WHICH BIND TO CANCER CELLS AND TARGET RADIONUCLIDES TO S...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

ANTI-PD1 ANTIBODIES AND METHODS OF USE

Antibodies binding To HLA-A2/WT1

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

TREATMENT OF CANCER USING A HLA-A2/WT1 X CD3 BISPECIFIC ANTIBODY AN...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

PREVENTION OR MITIGATION OF T-CELL ENGAGING AGENT-RELATED ADVERSE E...

BISPECIFIC ANTIGEN BINDING MOLECULES COMPRISING LIPOCALIN MUTEINS

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

MULTISPECIFIC ANTIBODIES

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIV...

BIVALENT, BISPECIFIC ANTIBODIES

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES